Skip to main content
SpringerLink
Log in

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol

  • Session X: Treatment: PTH And Calcitonin
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kalu DN, Pennock J, Doyle FH, et al. Parathyroid hormone and experimental osteosclerosis. Lancet 1970;1:1363–6.

    Google Scholar 

  2. Hefti E, Trechsel U, Bonjour J-P, et al. Increase of whole body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 1982;62:389–96.

    Google Scholar 

  3. Podbesek R, Edouard C, Neunier PG, et al. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 1983;112:1000–6.

    Google Scholar 

  4. Gunness-Hey M, Hock JM. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 1984;5:177–81.

    Google Scholar 

  5. Tarn CS, Heersche JNM, Murray TM, et al. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 1982;110:506–12.

    Google Scholar 

  6. Mosekilde Li, Sogaard CH, Danielson CC, et al. The anabolic effects of human parathyroid (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology 1991;129:421–8.

    Google Scholar 

  7. Reeve J, Meunier PJ, Parsons JA, et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. BMJ 1980;280:1340–4.

    Google Scholar 

  8. Neer RM, Slovik DM, Tully G, et al. Interactions of synthetic human parathyroid hormone fragment 1-34 with other agents in osteoporotic patients. In: DeLuca H, et al, editors. Osteoporosis. Baltimore: University Park Press, 1981:467–70.

    Google Scholar 

  9. Hodsman AB, Fraher LJ. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients. Bone Miner 1990;9:137–52.

    Google Scholar 

  10. Slovik DM, Rosenthal DI, Doppelt SH, et al. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone-(1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1986;1:377–81.

    Google Scholar 

  11. Slovik DM, Daly MA, Doppelt SH, et al. Increases in vertebral bone density of postmenopausal osteoporotics after treatment with hPTH-(1-34) fragment plus 1,25-(OH)2D3. In: Cohn DV, Martin TJ, Meunier PJ, editors. Calcium regulation and bone metabolism: basic and clinical aspects. Amsterdam: Elsevier, 1987:119–22.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

    M. Neer, D. M. Slovik, M. Daly, T. Potts Jr. & S. R. Nussbaum

Authors
  1. M. Neer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. M. Slovik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Potts Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. R. Nussbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neer, M., Slovik, D.M., Daly, M. et al. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporosis Int 3 (Suppl 1), 204–205 (1993). https://doi.org/10.1007/BF01621907

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01621907

Keywords

Search

Navigation